Long
Updated

ALXN

312
LONG TERM: 4hr ascending triangle with hidden bullish divergence + three rising vallyeys. They just got bought by AstraZeneca for $39 billion so we shall see how that affects the price, but I charted this like I would anything else. Bloomberg reports, "the offer values Alexion at $175 a share, a 45% premium to the closing price on Friday". (Not financial advice)
Note
gapped up pre-market, never provided entry

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.